2026-10-20
<!-- d1_scan_through_utc: 2026-10-20T22:30:00Z -->

# Daily Market Development Scan — 2026-10-20 (Tue, MT)

Scan window: 2026-10-19 16:25 MT → 2026-10-20 16:30 MT (~24h). The start comes from the prior `Daily.md` marker `2026-10-19T22:25:00Z`, and that file's commit (22:26:11Z) agrees. The window holds **one completed US trading session, Tuesday 2026-10-20**, plus 10-19 after-close releases, which react on 10-20. Releases after the 10-20 close (NFLX, ISRG, COF, CB, UAL and others) react on 10-21 and are pending.

Tape: **a rotation out of the AI and mega-cap trade into healthcare, banks and small caps on a heavy earnings day.**
- **Indices.** IBKR regular-session closes, 10-19 → 10-20: SPY 766.48 → **769.05 (+0.3353%)**, QQQ −0.1016%, **IWM +1.6588%**, DIA +1.0483%, **RSP +1.1528%**, SMH −0.3829%. SPY closed +0.10% above its 50-day SMA of closes (768.29). The trend call is D2a's.
- **VIX 17.31 (−1.13)**, from IBKR (CBOE index bar; 18.44 on 10-19).
- **Rates.** 10Y 5.12% (−3bp), 2Y 4.79% (+2bp), 30Y 5.42% (−6bp), from FMP treasury-rates pinned to 10-20. TLT rose +0.84% and HYG was flat.
- **Oil.** **The 10-20 Brent and WTI December settles are not confirmed**, so no 10-20 level is quoted. The last confirmed Brent settle is $109.55 on 10-19 (Reuters). Intraday 10-20, Brent December traded about $109.90–111.42 (WSJ, CNBC). USO fell −0.12% and GLD −0.54%.
- **Leadership.** XLV +2.37 led and XLRE +1.70 followed. XLK −0.28 was the only sector down.

## TL;DR

- **Exits triggered: none.** Twelve Strategy D tranches carry no mechanical trigger. RTX and ISRG both reported Q3 inside the window, and neither breached any criterion.
- **New entry candidates: none routed.** Twelve names cleared Strategy B's frozen ≥5% floor on own events. B is `DO-NOT-ACTIVATE` and capital-disabled, so the 11 eligible names go to the index only: **BRZE, HAS, EFX, LION, PAC, GM, MMM, GPC, MSCI, VICR, UCB**. AERO is an ineligible ADR.
- **Add candidates: none (0 of 12).** RTX and ISRG show strengthened conviction, but D is `DO-NOT-ACTIVATE` and capital-disabled.
- **Watchlist: 11 changes.** ADD the eleven names above to the Strategy B new-entry index.
- **Regime review: no review.** VIX eased to 17.31 and breadth rose to **53.28**. New IRGC Hormuz mine claims fall inside the standing `acute` shock overlay.

Park: VOO-only pin verified

Paper book (J): 120 calls, 0/30 realized, net_mu n/a, ready=FALSE

---

## DEVELOPMENTS

### 1. Market-wide breaking events

- **Gulf / Hormuz.**
  - **10-20.** The IRGC said two "non-compliant" tankers were set ablaze after hitting its mines in Hormuz (Tasnim, via CNBC). It also claimed a mine strike on a tanker on 10-18.
  - **Houthis** claimed strikes on Saudi energy sites (Aramco Yanbu and Shaybah); these are unconfirmed.
  - **Flows.** Kpler counts at least 18 vessels fired on in two weeks, with Hormuz crude flows around 8.5 mb/d last week. Energy Secretary Wright puts Gulf flows at ~80% of pre-conflict.
  - **Russia.** The US is easing some Russian oil sanctions (a diesel deal), and lawmakers are resisting.
  - Saudi Arabia postponed FII to 2027. Oil firmed early on 10-20; the settle is unconfirmed.
- **AI-credit stress.**
  - CoreWeave 5-year CDS ended 10-19 near 1,090bp, about 3x a year earlier (Bloomberg data via Yahoo).
  - CRWV hit its lowest since May 2025 early on 10-20, then bounced.
  - CNBC reports Oracle debt is near junk, with downgrade risk.
  - Semicap and AI-chip names lagged (LRCX −3.21, KLAC −2.80, ARM −3.07) while software rebounded.
- **No Anthropic or OpenAI funding or compute-commitment event** was found in the window. That means nothing was found, not that none exists.

### 2. Scheduled events that resolved in the window

- **Enumeration.**
  - The Nasdaq key-less calendar for 10-19 and 10-20 was fetched with curl and filtered to ≥$2B.
  - Release times come from issuer releases or EDGAR acceptance stamps. **EDGAR acceptance is an upper bound**, except where noted.
  - FMP's calendar was not used for enumeration.
- **Macro.**
  - No US data release on 10-20 was identified.
  - The Fed is in blackout; the FOMC meets 10-27/28. CME FedWatch showed 82.8% for a hold (premarket). BofA still calls an October hike.
- **Earnings, 10-19 after close (react 10-20).**
  - FNB EPS was $0.43, in line (PR Newswire, 16:31 ET).
  - AGNC net spread income was $0.37/share vs $0.39 expected.
  - Regional banks mostly beat: ZION, WAL, BOKF, WTFC, RLI, SFBS.
  - AERO posted record Q3 revenue (6-K at ~17:34 ET).
  - WRB, CCK and STLD moved less than 2% on 10-20.
- **Earnings, 10-20 pre-open.**
  - **GM:** adj EPS $3.70 vs $3.55 and a $20B buyback, yet the stock fell −6.84%. The release states 06:30 ET.
  - **HAS:** adj EPS $2.90 vs $1.86, with the outlook raised.
  - **EFX:** adj EPS $2.26 vs $2.19, but the FY revenue guide was cut.
  - **MMM:** adj EPS $2.50 vs $2.41, with the guide raised.
  - **GPC:** a slight miss, with the guide top cut.
  - **MSCI:** adj EPS $5.11 vs $4.98.
  - **NOC:** EPS $7.89 vs $7.22, with the guide raised.
  - **GE:** a beat with the guide raised, yet the stock fell −3.67%.
  - **KEY:** EPS $0.51 vs $0.46.
  - **VICR:** revenue +78.5% with a small EPS miss.
  - **PAC:** revenue +21.8%.
  - **UCB:** the print is distorted by one-offs.
- **Held names: RTX (pre-open) and ISRG (after close).** Both were read from the issuers' 8-K Ex-99.1; see the risk section below.
- **Earnings, 10-20 after close (pending; react 10-21).**
  - **NFLX:** Q3 revenue $12.9B (+12%), FY26 guide $51.1B.
  - **COF:** adj EPS $6.69 vs $5.45.
  - **CB:** core EPS $7.66 vs $6.53.
  - **UAL:** adj EPS $2.54 vs $2.60, with Q4 revenue guided above +20%.
  - Also: EWBC, NLY, ADC, HWC, PEGA, WFRD, NP, ALK, LRN.
- **Not verified.**
  - ELS, OZK and AMX: no issuer release found.
  - SMMT and CLBK: no 8-K.
  - OMC reports 10-22, outside the window.
  - Revenue consensus was not sourced for any print.
- **FDA.**
  - **GSK Jemperli** (dostarlimab) accelerated approval for Stage II/III MSI-H/dMMR locally advanced rectal cancer, dated 10-19. The fda.gov page summary was seen via search, but a direct fetch returned 401. **Sponsor and status are unresolved against the FDA page itself**, and the release time is not established.
  - **GSK's hepatitis B drug approval** (Reuters headline, 10-20) is **unresolved against FDA pages**.

### 3. Large single-name moves — AI-SIGNIFICANCE SCREEN

Durable record: **`ec09d8fc-29d6-42fc-92a8-ce292d0501d5`** (`research-screen`, `single-name-move`). **`surfaced_count` = 15 = ARRAY_LENGTH(passed); rail_tally 24; universe_measured 193.**

**Population (selection_rule).** IBKR daily bars, close array, 10-19 → 10-20:
- a fixed sweep of 159 US large caps;
- every ≥$2B Nasdaq-calendar reporter from 10-19 after close and 10-20 pre-open (30 measured, 26 of them outside the sweep);
- 8 names off discovery (FMP gainers, losers and most-active, plus 3 wide news searches).

Names below $2B were dropped on the FMP `profile-symbol` cap.

**Clear the B floor (≥5%) on an own event.**

| Name | Move (prior → event close) | Event | Anchor / release | Cap | Conv. | Other ≥5% sessions |
|---|---|---|---|---|---|---|
| BRZE | **+51.6977%** (30.04 → 45.57) | Salesforce all-cash deal at $47.50 | 10-20 pre-open (halted pre-open; minute not captured) | $5.18B | 75 | 2 (10-07, 10-15) |
| LION | **+14.4068%** (10.62 → 12.15) | Bloomberg: revived ~$3.5B Legendary bid (unconfirmed) | 10-20 intraday | $3.62B | 60 | 0 |
| EFX | **+11.3325%** (158.57 → 176.54) | Q3 beat; FY revenue guide cut | 10-20 pre-open (EDGAR 06:31) | $20.7B | 60 | 1 (10-15) |
| HAS | **+11.1991%** (98.49 → 109.52) | Q3 beat; outlook raised; buyback doubled | 10-20 pre-open (EDGAR 06:32) | $15.4B | 75 | 0 |
| VICR | **+7.0589%** (190.68 → 204.14) | Q3 revenue +78.5%; small EPS miss | 10-20 pre-open (EDGAR 07:20) | $9.41B | 45 | **5** |
| PAC | **+7.0511%** (203.09 → 217.41) | 3Q26 revenue +21.8% (ADS, cap ≥$10B: eligible) | 10-20 pre-open (6-K 06:00) | $11.3B | 60 | 0 |
| GM | **−6.8399%** (82.75 → 77.09) | Q3 beat and $20B buyback; GMI EBIT −88% | 10-20 06:30 ET (stated) | $67.6B | 60 | 0 |
| AERO | **−6.3562%** (15.89 → 14.88) | Record Q3 revenue | 10-19 after close → reaction 10-20 | $2.17B | 45 | 0 |
| MMM | **+5.7774%** (162.01 → 171.37) | Q3 beat; guide raised | 10-20 pre-open (EDGAR 06:35) | $88.4B | 60 | 0 |
| GPC | **−5.1160%** (130.18 → 123.52) | Slight miss; guide top cut | 10-20 pre-open (EDGAR 07:47) | $17.0B | 60 | 0 |
| MSCI | **+5.0045%** (563.49 → 591.69) | Q3 beat | 10-20 pre-open (EDGAR 06:46) | $43.0B | 60 | 0 |
| UCB | **+5.0030%** (33.78 → 35.47) | Q3 distorted by one-offs; KRE +1.96 | 10-20 pre-open (EDGAR 07:00) | $4.25B | 45 | 0 |

- **AERO is instrument-ineligible for B.** It is a foreign ADS with a $2.17B cap, below Rev 49's $10B ADR line. It is written up as context only.
- **BRZE is pinned to a cash deal price.** That makes B criteria 2 and 4 (mispricing vs information) the crux.
- **LION** rests on an anonymous-source report.
- **VICR** carries five other ≥5% sessions in its window, so it is not a clean single-event reaction.
- **MSCI and UCB** sit on the floor: +5.0045% and +5.0030%.

**Written up below the floor (`below_spec_floor`).**
- NOC +4.5726% (510.65 → 534.00): beat and guide raise.
- GE −3.6655% (311.28 → 299.87): sold the news on a beat and raise.
- KEY +4.4679% (19.92 → 20.81): about 2.5pp of the move is idiosyncratic against KRE.

**Rejected (≥5%, no own event).**
- **MDB +5.0159%** (348.69 → 366.18): a software-wide rebound after 10-16's −7.89%. An unverified CEO-departure headline (Yahoo/Insider Monkey) is an open lead, not a dated release.
- **RKT +5.042%** (10.71 → 11.25): rate-relief housing beta.

**Context under the floor.**
- MSTR +4.93: no cause found.
- Healthcare rotation: BMY +4.84, LLY +3.49 (record high).
- Software rebound: WDAY +4.50, ADBE +3.90.
- 10-19 after-close prints: AGNC +4.27 and FNB +4.13 (in-line).
- NU +4.00 on a UBS price-target raise.
- Semicap weakness: LRCX −3.21, ARM −3.07.

**Checks and gaps.**
- **Close-chain check ran: 2 hits, IRON and CLF.** Today's prior closes (78.93, 14.10) equal the 10-19 items' event closes in `c7045f5f`. Both anchors are 10-19 pre-open, so today's pair is the session *after* their measured reactions. The earlier dispositions are carried forward, and neither is re-written. No written item hit. Coverage is about 32%, so a clean pass is not a clearance.
- **Release minutes are upper bounds** (EDGAR acceptance) except GM and FNB. Revenue consensus is unsourced.
- **Causes not established** for MDB, MSTR, ON and NXPI.

### 4. Sector-level moves — AI-SIGNIFICANCE SCREEN

Durable record: **`af249738-e165-4fc8-8ba4-a5f2c1f6dd35`** (`research-screen`, `sector-move`). `surfaced_count` 3, rail_tally 5, universe 11, dispersion 2.65pp.

- **First-use guard: passed.** The 10-19 closes for XLU (41.36), XLY (114.46) and XLK (185.96) equal the 10-19 screen's event closes.
- **XLV +2.3740%** (175.65 → 179.82), conviction 60, `legacy_rule_pass` TRUE. Reuters wires (14:01 and 16:55 ET) put healthcare at the top of the S&P sectors and at a record, attributing it to rotation out of the AI trade. No drug-pricing or policy event was found.
- **XLF +1.1987%** (55.06 → 55.72), conviction 45. A run of regional-bank beats sent KRE up +1.96%.
- **XLK −0.2796%** (185.96 → 185.44), conviction 45, dispersion-only (`legacy_rule_pass` FALSE). Tech fell on a day RSP rose +1.15 and IWM +1.66. Semicap and AI chips lagged while software rebounded.
- **Not surfaced.**
  - XLRE +1.70 and XLU +1.26 are rate beta (TLT +0.84).
  - XLY +0.91, XLP +0.62, XLB +0.55, XLE +0.25, XLC +0.09, XLI +0.07.
  - XLE carries no oil level for 10-20, because the settle is unconfirmed.

### 5. Notable commentary

- **Morgan Stanley** (Wilson and Amato) says the correction is nearly over; Amato sees the S&P at 8,300 by May 2027.
- **JPMorgan** (Matejka) sees relief ahead for equities. **Evercore** flags levels that would turn the AI bull into a correction. **Yardeni** published "Why AI May Be Too Big to Fail".
- **BofA** (Bhave) keeps a non-consensus October hike call. **Waller** is not "greatly concerned" about a slowdown.
- **Analyst actions.** UBS raised its NU price target to $20.50. The market reaction to the strategy notes was not measured.

## ANALYSIS — RISK TO EXISTING POSITIONS

### Mechanical exit-trigger sweep

Run for **every** position over the **union** of `state.current_positions` and live `get_account_positions`.

- **Twelve tranches, all Strategy D, eight names.** `convergence_target` and `time_exit_date` are NULL on all twelve, so **no mechanical exit trigger can fire**.
- **The union is clean.** Broker quantities equal BigQuery's per-name tranche sums exactly: AMZN 0.3464, DIS 0.7244, GEV 0.1244, GOOGL 0.2577, ISRG 0.1091, RTX 0.1601, TSM 0.155, UBER 0.5156. **No reconciliation-lag position exists, so no alert is owed.**
- **Park:** VOO 17.7307 and no SGOV row, which matches the VOO-only pin.

### Per-strategy kill-trigger sweep

- **Strategy D** (`perf.kill_flags` as of 2026-10-19): `current_drawdown` −2.94%, `excess_vs_sgov` +5.53%, `deployed_days` 122. All five flags are FALSE, including `evidence_kill`.
  - **Refreshed on the 10-20 IBKR closes:** the D book's market value moved 551.23 → **550.49 (−0.13%)**. That puts drawdown at about **−3.1%** from peak, nowhere near the −50% kill.
- **A, B, C, E:** no open positions. B's flags are stale (as of 2026-08-18; capital-disabled), all FALSE.
- **No `interim_underperf_warning` alert is open or owed. B pairwise correlation is inert:** `n_positions = 0`.

### Thesis-invalidation review

**No Development met any entry-record criterion.**

- **RTX** +0.64%. Q3 2026 was released 10-20 (8-K Ex-99.1, accession 0000101829-26-000030; the 8:30 ET call implies pre-open).
  - Sales were $24.97B (+12% organic) and adj EPS $2.26.
  - **c4 backlog: $340B, up from $289B.** **c5: the FY26 FCF guide was raised to $9.0–9.2B**, well above the $7.5B floor.
  - **c2:** the only charge was about $0.36B (a P&W customer bankruptcy). That is not a quality event and is under $1B.
  - c1 (Airbus) and c3 (GTF Advantage) have no new information. c6 is not engaged.
  - **UNBREACHED.**
- **ISRG** +1.11% (pre-release session). Q3 was released 10-20 after the close (8-K Ex-99.1, accession 0001035267-26-000067; 1:30pm PDT call). The anchor is 10-20 and the reaction is 10-21.
  - **c1:** da Vinci procedures grew about 14% YoY, above the 10% line (Q1 16%, Q2 15%).
  - **c2:** placements were 546 vs 427.
  - **c3:** I&A grew 18%, above procedure growth.
  - **c4:** no competitor displacement is disclosed. That is nothing found, not a verified negative.
  - **UNBREACHED.**
- **AMZN** +0.07%, **GOOGL** −1.14%, **TSM** +1.16%, **GEV** −1.99%, **UBER** −1.46%, **DIS** +1.90%: no criterion-relevant development was found. One wide search returned mostly stale items, so this is not a verified negative.
  - TSM's 10-15 Q3 print was not retrieved this run.
  - Next prints (approximate, not issuer-confirmed): GOOGL 10-27/28, AMZN 10-29, UBER 10-29 to 11-03, DIS mid-November. GEV's date is unverified.

**No price-level criterion is held, so no dividend-netting test was reached.** **Watchlist:** no Development changed the candidacy of any Strategy A queue name, and A remains `DO-NOT-ACTIVATE`.

## ANALYSIS — OPPORTUNITY CHECK

Evaluated against the reactive-cadence roster set (A, B, C, E).

- **Strategy B — eleven eligible names clear the frozen ≥5% floor on own-event anchors; none is routed.** B is `DO-NOT-ACTIVATE` (10-06) and capital-disabled, so no `thesis-construction` identity is minted. All eleven are indexed (§3). AERO is excluded on the instrument rule.
  - On criterion 4 (information vs sentiment), GM and GE are the interesting cases: both moved *against* fundamental beats.
  - BRZE is a deal-pinned target, and LION rests on an unconfirmed bid report.
- **Strategy A — no new candidate.**
- **Strategy C — no new candidate.** C is FOMC-only. `thesis-FOMC-C-20261020` (10-28 FOMC) stays in the pipeline, and CME odds (~83% hold) are context for it.
- **Strategy E — no new candidate.** The semicap vs analog split (LRCX and KLAC down; ON and NXPI up) has no identified driver, and E is `DO-NOT-ACTIVATE`.

## ANALYSIS — ADD-CANDIDATE CHECK (Strategies A, B, D only)

Durable record, including every decline: **`11513062-0d2f-4a1e-92d7-6ffe3993af5f`** (`add-candidate-review`). **12 evaluated, 0 flagged, 0 declined at the HARD GATE.**

| Position | mark vs cost | Trigger | Disposition |
|---|---|---|---|
| D:ISRG:2026-07-20 | +25.3181% | strengthened-conviction | declined |
| D:RTX:2026-04-27 | +9.2941% | strengthened-conviction | declined |
| D:AMZN:2026-07-09 | +8.8648% | none | declined |
| D:TSM:2026-07-29 | +8.1951% | none | declined |
| D:DIS:2026-08-05 | +7.5970% | none | declined |
| D:GOOGL:2026-07-26 | +3.7904% | none | declined |
| D:DIS:2026-05-07 | +0.3153% | none | declined |
| D:TSM:2026-07-21 | −0.6500% | dip-with-intact-thesis | declined |
| D:AMZN:2026-07-30 | −1.1528% | dip-with-intact-thesis | declined |
| D:GOOGL:2026-07-09 | −5.4407% | dip-with-intact-thesis | declined |
| D:UBER:2026-07-09 | −5.8291% | dip-with-intact-thesis | declined |
| D:GEV:2026-08-03 | −8.2045% | dip-with-intact-thesis | declined |

- **Price basis.** The numerator is the 2026-10-20 IBKR daily bar close; the denominator is the tranche's own `cost_basis / shares`.
- **HARD GATE — clear on all 12.** The three-disjunct, COALESCE-wrapped test returns 0. It was re-read immediately before the append; D2a had not run and no position event has landed since 10-19.
- **Why everything is declined.** D is `DO-NOT-ACTIVATE` and capital-disabled, so no add has a funding path. The RTX and ISRG prints *reinforce* their theses (strengthened-conviction) but do not change that.

## ANALYSIS — REGIME CHECK

**NO inter-monthly router review is recommended.**

- `state.current_regime` STRATEGY_ACTIVATION:
  - B and D `DO-NOT-ACTIVATE` (10-06);
  - A `DO-NOT-ACTIVATE` (10-02);
  - C `HYBRID ACTIVATE (FOMC-only)`;
  - E `DO-NOT-ACTIVATE — PENDING div-E-202610-1` (D2's 10-19 held state).
- FUNDAMENTAL_AXIS (as of 10-01) reads stable growth, stable inflation, hawkish policy, neutral risk sentiment, shock overlay **acute**.
- **Geopolitical trigger.**
  - The dated 10-20 items are the IRGC claim of two tankers set ablaze by mines in Hormuz, plus unconfirmed Houthi strike claims on Saudi sites.
  - **The standing `shock_overlay` is already `acute`**, so a further qualifying event is already inside the standing grade: the rubric goes no higher than `acute`, and a new event only restarts the de-escalation clock that M1a and M1R read for themselves. **So no flag is owed.**
- **Measured triggers** are D2's to detect and are not computed here.
  - VIX eased to 17.31, inside NORMAL.
  - SPY 769.05 closed just above its 50-day SMA of closes (768.29). The trend class is D2a's call.
  - Breadth is 53.28, up 2.59pp.
- None of this can move an activation while the acute override binds. Default NO.

## EQUITY-BREADTH OBSERVATION

**53.28** for session **2026-10-20**, written to `events.regime_events` (`TECHNICAL_INPUT` / `EQUITY_BREADTH_PCT`). D2a owns the HEALTHY/WEAK call.

- **Barchart `$S5TH`** (`tavily_extract` advanced, cache-busted) is headed "Quote Overview for Tue, Oct 20th, 2026" and reads **53.28 +2.59 (+5.11%) at 17:03 ET**. Previous Close is 50.69, equal to the stored 10-19 value, so there is no revision. O 52.88 / H 54.87 / L 51.68: not a carry, and not an exact repeat.
- **EODData** settled row "20 Oct 26" reads O 52.88 / H 54.87 / L 51.68 / **C 53.28**. Its quote box showed an anomalous 53.08 with no timestamp, so the settled row was used. **Barchart and EODData are one feed, so this run has a single usable source.**
- **Independent check, ChartRow:** "as of market close, Oct 20, 2026", 264 of 497 eligible (53.12%).
  - Against its 10-19 reading of 50.30, that is +2.82pp, versus +2.59pp on `$S5TH`. So `chartrow_dod_gap=0.23`, and the direction agrees.
- **MacroMicro was not probed.** The re-probe runs on Sundays only.

## RECOMMENDED ACTIONS

**Exits triggered: none.** No open position carries a mechanical trigger, and no Development met any thesis-invalidation criterion. The RTX and ISRG Q3 prints both leave every criterion unbreached.

**New entry candidates: none routed.** Strategy B is `DO-NOT-ACTIVATE` and capital-disabled. The eleven eligible own-event B-floor clearers are indexed below instead.

**Add candidates: none.**

**Router reviews: none.**

Watchlist updates go to the Strategy B new-entry index. Each window runs 10 trading days from the anchor, and D2 computes the close date on the inclusive convention. Source `research-screen` `ec09d8fc-29d6-42fc-92a8-ce292d0501d5`.

- ADD **BRZE** (Strategy B, `qualifying_event_date` 2026-10-20) — +51.6977% (30.04 → 45.57) on the pre-open Salesforce all-cash deal at $47.50; index only. It is pinned to the deal price, so criteria 2 and 4 are the crux. Two other ≥5% sessions are in the window.
- ADD **HAS** (Strategy B, `qualifying_event_date` 2026-10-20) — +11.1991% (98.49 → 109.52) on its pre-open Q3 beat, raised outlook and doubled buyback; index only.
- ADD **EFX** (Strategy B, `qualifying_event_date` 2026-10-20) — +11.3325% (158.57 → 176.54) on a pre-open Q3 beat with an FY revenue guide cut; index only. One other ≥5% session is in the window (10-15).
- ADD **LION** (Strategy B, `qualifying_event_date` 2026-10-20) — +14.4068% (10.62 → 12.15) on an intraday Bloomberg report of a revived ~$3.5B Legendary bid (unconfirmed); index only.
- ADD **PAC** (Strategy B, `qualifying_event_date` 2026-10-20) — +7.0511% (203.09 → 217.41) on pre-open 3Q26 results; index only. It is an ADS with an $11.3B cap, so it is eligible under Rev 49.
- ADD **GM** (Strategy B, `qualifying_event_date` 2026-10-20) — −6.8399% (82.75 → 77.09) on its 06:30 ET Q3 release (a beat plus a $20B buyback, but GMI EBIT −88%); index only. The move runs against the beat, which bears on criterion 4.
- ADD **MMM** (Strategy B, `qualifying_event_date` 2026-10-20) — +5.7774% (162.01 → 171.37) on its pre-open Q3 beat and guide raise; index only.
- ADD **GPC** (Strategy B, `qualifying_event_date` 2026-10-20) — −5.1160% (130.18 → 123.52) on its pre-open Q3 slight miss and guide-top cut; index only.
- ADD **MSCI** (Strategy B, `qualifying_event_date` 2026-10-20) — +5.0045% (563.49 → 591.69) on its pre-open Q3 beat; index only. The move sits on the floor.
- ADD **VICR** (Strategy B, `qualifying_event_date` 2026-10-20) — +7.0589% (190.68 → 204.14) on its pre-open Q3 (revenue +78.5%); index only. **Five other ≥5% sessions are in the window.**
- ADD **UCB** (Strategy B, `qualifying_event_date` 2026-10-20) — +5.0030% (33.78 → 35.47) on its pre-open Q3, which is distorted by one-offs (KRE +1.96); index only. The move sits on the floor.

```yaml d1_actions
- action: watchlist
  ticker: BRZE
  strategy: B
  qualifying_event_date: 2026-10-20
  source_research_screen_id: ec09d8fc-29d6-42fc-92a8-ce292d0501d5
  detail: ADD to B new-entry index — +51.6977% on pre-open 10-20 Salesforce all-cash deal at $47.50; deal-pinned (criteria 2/4 crux); index only; 2 other >=5% sessions in window
- action: watchlist
  ticker: HAS
  strategy: B
  qualifying_event_date: 2026-10-20
  source_research_screen_id: ec09d8fc-29d6-42fc-92a8-ce292d0501d5
  detail: ADD to B new-entry index — +11.1991% on pre-open 10-20 Q3 beat, outlook raised, buyback doubled; index only
- action: watchlist
  ticker: EFX
  strategy: B
  qualifying_event_date: 2026-10-20
  source_research_screen_id: ec09d8fc-29d6-42fc-92a8-ce292d0501d5
  detail: ADD to B new-entry index — +11.3325% on pre-open 10-20 Q3 beat with FY revenue guide cut; index only; 1 other >=5% session in window (10-15)
- action: watchlist
  ticker: LION
  strategy: B
  qualifying_event_date: 2026-10-20
  source_research_screen_id: ec09d8fc-29d6-42fc-92a8-ce292d0501d5
  detail: ADD to B new-entry index — +14.4068% on intraday 10-20 Bloomberg report of revived ~$3.5B Legendary bid (unconfirmed); index only
- action: watchlist
  ticker: PAC
  strategy: B
  qualifying_event_date: 2026-10-20
  source_research_screen_id: ec09d8fc-29d6-42fc-92a8-ce292d0501d5
  detail: ADD to B new-entry index — +7.0511% on pre-open 10-20 3Q26 results; ADS cap $11.3B >= $10B ADR line (Rev 49) eligible; index only
- action: watchlist
  ticker: GM
  strategy: B
  qualifying_event_date: 2026-10-20
  source_research_screen_id: ec09d8fc-29d6-42fc-92a8-ce292d0501d5
  detail: ADD to B new-entry index — -6.8399% on 06:30 ET 10-20 Q3 (beat + $20B buyback, GMI EBIT -88%); move against the beat bears on criterion 4; index only
- action: watchlist
  ticker: MMM
  strategy: B
  qualifying_event_date: 2026-10-20
  source_research_screen_id: ec09d8fc-29d6-42fc-92a8-ce292d0501d5
  detail: ADD to B new-entry index — +5.7774% on pre-open 10-20 Q3 beat and guide raise; index only
- action: watchlist
  ticker: GPC
  strategy: B
  qualifying_event_date: 2026-10-20
  source_research_screen_id: ec09d8fc-29d6-42fc-92a8-ce292d0501d5
  detail: ADD to B new-entry index — -5.1160% on pre-open 10-20 Q3 slight miss and guide-top cut; index only
- action: watchlist
  ticker: MSCI
  strategy: B
  qualifying_event_date: 2026-10-20
  source_research_screen_id: ec09d8fc-29d6-42fc-92a8-ce292d0501d5
  detail: ADD to B new-entry index — +5.0045% on pre-open 10-20 Q3 beat; sits on the floor; index only
- action: watchlist
  ticker: VICR
  strategy: B
  qualifying_event_date: 2026-10-20
  source_research_screen_id: ec09d8fc-29d6-42fc-92a8-ce292d0501d5
  detail: ADD to B new-entry index — +7.0589% on pre-open 10-20 Q3 (revenue +78.5%); 5 other >=5% sessions in window prejudice criteria 2 and 4; index only
- action: watchlist
  ticker: UCB
  strategy: B
  qualifying_event_date: 2026-10-20
  source_research_screen_id: ec09d8fc-29d6-42fc-92a8-ce292d0501d5
  detail: ADD to B new-entry index — +5.0030% on pre-open 10-20 Q3 distorted by one-offs (KRE +1.96); sits on the floor; index only
```

## PROCESS NOTES

- **Pre-flight.**
  - BigQuery, which was de-authed this morning (OPS1 and M1R halted), answered normally for this run. IBKR is live.
  - The run is logged on branch `claude/d1-2026-10-20`. The double-run guard found no prior completion.
  - Git history is complete (`--is-shallow-repository` false).
- **Park pin check.** `state.park_policy_current` reads `('VOO', 0, 'VOO', 'VOO')` and `state.park_menu` is exactly `VOO`. The pin holds, and the `loop:park_allocator` heartbeat was written.
- **News-reaction paper book (J lead), first scoring day.**
  - **Marks.** Nasdaq historical rows were fetched for all 41 tickers, and 410 rows (10-06..10-19) were inserted into `events.news_reaction_marks`.
    - **Nasdaq had not yet published the 10-20 bar at ~16:10 MT.** It self-heals on the next run inside the D−14 window.
  - **Calls.** Google News RSS gave 120 headlines (3 per ticker × 40, published since the window start). There were 5 blind Sonnet reads, and 120 calls were written.
    - The modal votes were UP 25, DOWN 17 and FLAT 78. 19 modal-UP calls clear the 0.8 gate (11 DOWN at the gate, recorded only).
  - **Readiness:** `n_realized` 0 of 30, `ready` FALSE, so nothing was enqueued. No ticker was skipped.
  - The feeds were fetched with `curl` (the same key-less endpoints the spec names for WebFetch), so no `ops.web_calls` rows are owed for them.
- **Write-integrity incident, found and repaired in-run.**
  - The 120-row calls INSERT was handed to a Sonnet executor. Because the MCP tool cannot take a file, it hand-retyped the ~30KB SQL.
  - A per-row fingerprint readback against the local source found **3 corrupted `source_url` values** (JPM `e221f9c5`, NVDA `96f85048`, WMT `499f6487`). Every scoring field (hash, ticker, direction, agreement, votes, timestamps, headline) matched on all 120 rows.
  - The three URLs were corrected with a hash-guarded `UPDATE`, scoped to this session's rows, in which the replacement was required to hash to the source value.
  - The 410 marks verified byte-exact by checksum.
  - **Lesson:** later D1 runs should not delegate large literal-SQL writes to a sub-agent. Write them from the orchestrator, or verify by fingerprint as done here.
- **Frontier-LLM capability check (Tuesday battery: prompt injection).**
  - One `hf_fs` paper search ("prompt injection LLM agents") returned five results. The newest is dated 2026-09-28, so **nothing was published since the window floor**.
  - No `[HF Frontier-LLM Capture]` entry and no strategy-candidate row were written. This is the known recency limitation (open notice owned by W5).
- **Durable records this run.**
  - `events.regime_events` 1 row (breadth 53.28 for 10-20).
  - `events.decision_log` 3 rows: `ec09d8fc` single-name screen, `af249738` sector screen, `11513062` add-candidate review. All three were checked after writing: `fields` parses, `routine='D1'` is on both screens, and `surfaced_count` equals `ARRAY_LENGTH(passed)` (15 and 3).
  - `ops.heartbeat` 1 row.
  - `events.news_reaction_marks` 410 rows and `events.news_reaction_calls` 120 rows.
  - `ops.web_calls` 71 rows.
- **Orchestration.** Six Sonnet workers ran, each with disjoint subjects and per-subject caps written into a shared rules file, plus one follow-up attribution worker:
  - IBKR tape and held book (IBKR only, 0 metered);
  - earnings reactors;
  - non-earnings movers;
  - macro, events and commentary;
  - held-book criteria;
  - breadth plus HF;
  - attribution (5 searches).

  Five blind readers and two SQL executors also ran.
  - **Metered total:** 71 calls, about 24.8 estimated credits (none reported by the provider). The orchestrator itself made no metered call.
  - **Caps.** The macro worker went over its S3 cap because the closing-wrap searches returned nothing, and it said so. The movers worker spent 2 calls on BRZE to confirm the release time.
- **Degraded legs, stated.**
  - The 10-20 oil settles are unconfirmed.
  - Jemperli and the GSK hepatitis B approval are unresolved against FDA pages (fda.gov returned 401).
  - Release minutes are EDGAR upper bounds, and revenue consensus is unsourced.
  - MDB, MSTR, ON and NXPI causes are unresolved.
  - Held-name non-earnings search was thin (not a verified negative), and TSM's 10-15 Q3 was not retrieved.
  - Breadth has one feed plus the ChartRow check.
